Doppler Ultrasound Systems Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Doppler Ultrasound Systems Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The Doppler ultrasound systems market is expected to register a CAGR of 7.5% over the forecast period (2022 - 2027).

The Covid-19 impacted the doppler ultrasound market significantly. A high rate of thrombotic events was associated with COVID-19 infection, such as deep vein thrombosis (DVT) and acute pulmonary embolism. Hence, the use of doppler ultrasound increased. For instance, the July 2021 article "Utility of Venous Doppler Ultrasound in COVID-19" noted that during the pandemic, an increased incidence of asymptomatic DVT (60.87 percent) was noted. It also mentioned that color doppler ultrasound allowed detection of DVT in asymptomatic patients, but Venous Doppler ultrasound was accepted to act as a critical intervention for COVID-19 patients at risk of thrombotic complications, which helped physicians to make decisions. Therefore, it was anticipated that the Covid-19 epidemic would have a favorable effect on the market.

The rising prevalence of chronic diseases, the aging population, rising healthcare spending in developed nations, a rise in healthcare providers, and rising healthcare spending on diagnosis are the main drivers of the market expansion under study. The development of doppler ultrasound diagnostic technologies is another important element fueling the expansion of the market under study. Additionally, rising awareness of early detection and treatment is anticipated to support market expansion in the future. Chronic diseases like cancer, cardiovascular, gastrointestinal, and kidney ailments are becoming more prevalent throughout the world. The primary driver of the analyzed market is still the rise in cancer incidence. For instance, according to the Global Cancer Observatory 2020, the estimated number of new cancer cases were 19.3 million in 2020, these cases are expected to increase and reach up to 30.2 million in 2040. Doppler ultrasounds for diagnostic reasons are now more in demand, and this trend is anticipated to continue over the projected period. The country's population is very likely to have a high prevalence of these illnesses, which is fueling the market's expansion. In addition, numerous studies are being conducted to determine the diagnostic use of the doppler ultrasound in various disorders. For instance, a team of researchers from Dalian Medical University in China began a study in July 2021 to investigate the diagnostic use of doppler ultrasound in patients with early chronic renal disease. Furthermore, in April 2022, a different team of researchers from the University of British Columbia in Vancouver, Canada, published their study on "Kidney Ultrasound for Nephrologists: A Review." Doppler imaging is frequently used to evaluate transplanted kidneys and is utilized to evaluate renal vascular flow and patency, according to their study. Thus, it is anticipated that the growing body of knowledge about doppler ultrasounds would open up new business prospects for doppler ultrasound systems and favorably impact market expansion as a whole.

The market participants are also concentrating on doppler ultrasound systems, which are driving market expansion. For instance, at the Arab Health 2020 conference in Dubai in January 2020, Trivitron Healthcare introduced 10 innovation-driven products in the Advanced Imaging modalities and Critical Care and Life Support segment, including SonoRad V10 - Color Doppler Ultrasound system in addition to other modalities. Additionally, Us2.ai, a Singapore-based MedTech company supported by Sequoia India and EDBI, gained FDA approval for Us2.v1, a fully automated cardiac ultrasound tool to measure 2D and doppler, in September 2021. Therefore, it is projected that during the course of the projection period, advances in the doppler ultrasound system will spur market expansion. Thus, the studied market growth is attributed to the above-mentioned factors and the market is expected to grow significantly over the forecast period.

However, Stringent regulatory policies and excessive cost of doppler ultrasound systems are expected to hamper the market growth.

Key Market TrendsHandheld Devices Type Segment is Expected to Grow at the Fastest Rate During the Forecast Period

Due to their simplicity of use and sophisticated capabilities, handheld Doppler ultrasound systems are predicted to have significant market expansion. The use of the devices to monitor blood flow in pregnant women as well as numerous other applications are also anticipated to fuel the segment's expansion. Handheld gadgets are practical to use and can keep up with the demanding and fast-paced healthcare setting. The majority of commercially available handheld devices offer simple scanning, smooth departmental changes, and seamless use for a variety of tests. Podiatrists routinely use handheld Doppler examinations as a non-invasive vascular assessment method. Because of these benefits, market actors are likely to demand further handheld device development. For instance, GE Healthcare, a part of General Electric, introduced the Vscan Air, a new wireless handheld ultrasound instrument, in March 2021. A pocket-sized ultrasound with color Doppler called the Vscan Air uses customer-driven innovation to offer more individualized care for patients all around the world.

Additionally, Royal Philips added improved hemodynamic assessment and measuring capabilities on its portable Lumify Pulse Wave Doppler ultrasound in February 2022, expanding its ultrasound line. Therefore, it is projected that these improvements will fuel market expansion in the sector. Additionally, it is anticipated that the segment expansion will soon be supported by the rising incidence of peripheral artery disease and venous thromboembolism. Although the exact number of people affected by deep vein thrombosis (DVT) or pulmonary embolism (PE) is unknown, DVT and PE impact 900,000 people annually in the United States, according to data from the Center for Disease Control and Prevention (CDC) updated in April 2022. Additionally, the rise in breast and stomach cancer incidence is anticipated to fuel demand, accelerating the market growth.

According to data from the World Health Organization (WHO) that was updated in March 2021, there were 7.8 million women alive at the end of 2020 who had received a diagnosis of breast cancer in the previous five years, making it the most common cancer in the world. In the year 2020, there were approximately 2.3 million women worldwide who were diagnosed with breast cancer. Thus, the demand for portable and handheld Doppler ultrasonography equipment for practical diagnosis purposes is rising as the prevalence of chronic diseases rises. As a result of the aforementioned factors, the market for handheld devices is anticipated to develop over the course of the projected period.

North America is Expected to Dominate the Market Over the Forecast Period

North America holds a major share in the doppler ultrasound systems market. Over the course of the forecast, it is anticipated to exhibit a similar trend. The United States contributed the highest share in North America. Key significant drivers of the market's expansion are the simplicity with which technologically advanced devices are available, the high acceptance of imaging, and the rise in chronic diseases throughout the nation.

The market for Doppler ultrasound systems in North America is expanding overall due to the rise in the application of imaging technologies for illness diagnosis and treatment. For instance, the wearable, wireless Doppler ultrasound system was introduced by Canadian startup Flosonics Medical in March 2022. Therefore, market expansion in the area is anticipated to be fueled by innovations.

Additionally, a rise in the number of hospitals, clinics, and ambulatory surgery centers (ACSs) across the nation is contributing to the market expansion. According to American Hospital Association (AHA) figures, there will be 6,093 operating hospitals in the country by the year 2020. As a result, the demand for medical imaging equipment such as doppler ultrasound systems is driven by a sharp increase in the number of hospitals and rising hospital admissions. Blood flow via veins and arteries is measured using Doppler ultrasonography equipment. This technology aids in the diagnosis of numerous ailments by producing colored outputs dependent on the quantity and direction of blood flow. As a result, it is anticipated that the county's growing number of hospitals and other care facilities will fuel market expansion. To further strengthen the healthcare infrastructure, public and private healthcare spending is rising sharply across North America. For instance, the governments of Canada and Quebec worked together to invest in 209 infrastructure projects to modernize, redevelop, and upgrade health and social services institutions in Quebec, including hospitals and other care centres. This information was provided in a press release issued by the Canadian government in July 2021. The investment for these 209 infrastructure projects would total USD 188.3 million, according to announcements from the federal ministers of infrastructure, communities, and health and social services. Due to these investments, hospitals must have access to cutting-edge medical equipment like doppler ultrasound systems. Additionally, as part of its strategy to eliminate hallway health care, the Canadian province of Ontario announced in March 2021 that it would pay up to USD 53 million to finance the design and construction of the new Grey Bruce Health Services Markdale Hospital. It is therefore anticipated that it will increase the use of doppler ultrasonography devices in Canada. It follows that further investment throughout the region's nations is expected to result in market expansion in the future. Therefore, owing to the previously mentioned factors the growth of the studied market is expected in the North American region.

Competitive Landscape

The doppler ultrasound systems market is moderately consolidated due to the presence of a few key players in the market. The companies are focusing on the technological advancement of the devices to gain significant market shares. Some of the market players are Koninklijke Philips N.V., General Electric Company (GE Healthcare), Siemens Healthcare GmbH, Fujifilm Corporation, Samsung, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Canon Inc., Trivitron Healthcare Private Limited, BK Medical Holding Company, Inc., CIMON Medical AS, NOVASIGNAL CORPORATION, ESAOTE SPA, and Clarius, among others.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.